Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.
Press releases published on December 18, 2025
December 18, 2025
AITX's RAD Introduces RAM, the ‘ROSA Accessory Module’, Expanding Agentic AI to Existing 3rd Party Cameras
Indeterminate
GlobeNewswire
December 18, 2025
Biodexa Announces Pricing of $10 Million Public Offering
Indeterminate
GlobeNewswire
December 18, 2025
Data Storage Corporation Provides Letter to Shareholders Highlighting 2026 Corporate Strategy
Indeterminate
GlobeNewswire
December 18, 2025
GSI Technology to Participate Virtually in the 28th Annual Needham Growth Conference on January 15, 2026
Indeterminate
GlobeNewswire
December 18, 2025
VisionWave Holdings Acquires Solar Drone Ltd., Advancing Autonomous Systems for Defense and Critical Infrastructure
Indeterminate
GlobeNewswire
December 18, 2025
Byrna Technologies to Ring the Nasdaq Opening Bell on December 22, 2025
Indeterminate
GlobeNewswire
December 18, 2025
Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026
Indeterminate
GlobeNewswire
December 18, 2025
Akari Therapeutics Releases Virtual Investor “What This Means” Segment
Indeterminate
GlobeNewswire
December 18, 2025
Applied Digital Completes Development Loan Facility with Macquarie Group to Support New AI Factory Campuses
Indeterminate
GlobeNewswire
December 18, 2025
Regula Wins High Customer Marks and Strong Momentum in G2’s Winter 2026 Grid Reports for Identity Verification
Indeterminate
GlobeNewswire
December 18, 2025
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
Indeterminate
GlobeNewswire
December 18, 2025
Clip Money Inc. Secures a US$3 Million Loan from BDC
Indeterminate
GlobeNewswire
December 18, 2025
Numab Therapeutics Achieves Milestone in Second Collaboration Project with Boehringer Ingelheim
Indeterminate
GlobeNewswire
December 18, 2025
First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D
Indeterminate
GlobeNewswire